ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,482.87
0.09%
Dow Jones
39,164.06
0.09%
US Dollar vs MXN
18.33276
-0.57%
Brent Oil
85.745
0.39%
Bitcoin
61,439.95
-0.28%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
28/06/202406:00Business WireEmera Announces Strategic Reallocation of Capital to Drive Long-Term Growth; Updates Growth GuidanceTSX:EMA.PR.BEmera Incorporated
28/06/202406:00GlobeNewswire Inc.Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell LymphomaNASDAQ:REGNRegeneron Pharmaceuticals Inc
28/06/202406:00Business WireMarqeta to Announce Second Quarter 2024 Results on August 7, 2024NASDAQ:MQMarqeta Inc
28/06/202406:00Business WireICE Benchmark Administration Provides Update Regarding the Cessation of U.S. Dollar LIBOR®NYSE:ICEIntercontinental Exchange Inc
28/06/202406:00GlobeNewswire Inc.Amwell Announces Reverse Stock SplitNYSE:AMWLAmerican Well Corporation
28/06/202406:00Business WireGlobal Medical REIT Inc. Releases Corporate Social Responsibility ReportNYSE:GMREGlobal Med REIT Inc
28/06/202406:00Business WirePositive Results from Osteoarthritis Clinical Study in Dogs Reported by Can-Fite’s Partner VetbiolixAMEX:CANFCan Fite BioPharma Ltd
28/06/202406:00GlobeNewswire Inc.CryptoSafe Unveils Safe Pay: A Game-Changer in Cryptocurrency Payment Solutions
28/06/202406:00GlobeNewswire Inc.23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker PanelNASDAQ:ME23andMe Holding Company
28/06/202406:00GlobeNewswire Inc.Plug to Receive Federal Clean Hydrogen Production Tax Credit at Georgia Hydrogen FacilityNASDAQ:PLUGPlug Power Inc
28/06/202406:00GlobeNewswire Inc.Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® IndexesNASDAQ:ELYMEliem Therapeutics Inc
28/06/202406:00Business WireMindMed to be Included in Russell 2000® and Russell 3000® IndexesNASDAQ:MNMDMind Medicine MindMed Inc
28/06/202406:00GlobeNewswire Inc.Esperion Announces Monetization of European Royalties and Concurrent Payoff and Termination of Existing Revenue Interest FacilityNASDAQ:ESPREsperion Therapeutics Inc
28/06/202406:00Business WireSierra Metals Commences Trading Activity on the Lima Stock ExchangeTSX:SMTSierra Metals Inc
28/06/202406:00Business WireF9 Investments Comments on Bloomberg Report That LL Flooring Has Hired a Consultant with Restructuring Capabilities and is Desperate for CashNYSE:LLLL Flooring Holdings Inc
28/06/202406:00GlobeNewswire Inc.Asset Entities Inc. Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid PriceNASDAQ:ASSTAsset Entities Inc
28/06/202406:00Business WireOne Energy to Host Virtual Analyst & Investor Day on Monday, July 1, 2024NYSE:TRTLTortoiseEcofin Acquisition Corp III
28/06/202406:00GlobeNewswire Inc.Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced MelanomaNASDAQ:IOVAIovance Biotherapeutics Inc
28/06/202406:00GlobeNewswire Inc.OTC Markets Group Welcomes Golden Metal Resources PLC to OTCQXAMEX:GMETVaneck Green Metals ETF
28/06/202406:00Business WireShorla Oncology Announces FDA Approval for TEPYLUTE, A Novel Formulation to Treat Breast and Ovarian Cancer
28/06/202406:00GlobeNewswire Inc.Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of DirectorsNASDAQ:VERVVerve Therapeutics Inc
28/06/202405:59Business WireBerkshire Hathaway Inc. News Release
28/06/202405:59PR Newswire (US)Comprehensively Covering Multiple Myeloma: IASO Bio's GPRC5D CAR-T Product RD118 Receives IND Approval from NMPA
28/06/202405:57GlobeNewswire Inc.Apellis Plans to Seek Re-Examination Following Negative CHMP Opinion for Pegcetacoplan for Geographic Atrophy (GA) in the EUNASDAQ:APLSApellis Pharmaceuticals Inc
28/06/202405:56GlobeNewswire Inc.Man Group PLC : Form 8.3 - Smith (DS) plc
28/06/202405:55Alliance NewsAlliance NewsIN BRIEF: Nightcap shares fall as proposes exit from AIMLSE:NGHTNightcap Plc
28/06/202405:54GlobeNewswire Inc.Crown Crafts Announces Financial Results for Fourth Quarter and Full Year Fiscal 2024NASDAQ:CRWSCrown Crafts Inc
28/06/202405:54PR Newswire (US)Bitget Wallet Announces Investment in New Asset Trading Platform Tomarket, Targeting Trillion-Dollar Markets Beyond DEXs
28/06/202405:53Business WireMerck Receives Positive EU CHMP Opinion for WINREVAIR™ (sotatercept) in Pulmonary Arterial Hypertension (PAH)NYSE:MRKMerck and Co Inc
28/06/202405:53PR Newswire (US)Beijing Review: Fairness Reigns

Su Consulta Reciente

BIT
I09774
XS2733507722 20280131 46...
BIT
P1YXO4
NLBNPIT1YXO4 20351221 2....
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados